Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Management of overweight and obesity in the adult.

BIBLIOGRAPHIC SOURCE(S)

  • Michigan Quality Improvement Consortium. Management of overweight and obesity in the adult. Southfield (MI): Michigan Quality Improvement Consortium; 2007 Mar. 1 p.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Michigan Quality Improvement Consortium. Identification, evaluation, and treatment of overweight and obesity in the adult. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Mar. 1 p.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The level of evidence grades (A-D) are provided for the most significant recommendations and are defined at the end of the "Major Recommendations" field.

Assessment of Body Mass Index (BMI)

  • Measure weight, waist circumference, and calculate patient's BMI1 to determine if patient is overweight or obese and pattern of weight change [C]
  • If overweight, assess for complicating risk factors:
    • Established coronary heart disease (CHD) or stroke
    • Other atherosclerotic disease
    • Type 2 diabetes
    • Sleep apnea
    • Smoking
    • High triglycerides
    • Hypertension
    • High low-density lipoprotein (LDL)
    • Low high-density lipoprotein (HDL)
    • Impaired fasting glucose
    • Family history of premature congenital heart disease (CHD)
  • Assess current eating, exercise behaviors, history of weight loss attempts, and psychological factors contributing to weight gain.

Frequency: At each periodic health exam; more frequently at the discretion of the physician

1BMI is an accurate proxy for body fat in average adults but may be misleading in muscular individuals.

Interventions to Promote Weight Management

Patients with BMI >25

Frequency: At each periodic health exam; more frequently at the discretion of the physician

2Avoid weight gain or maintain weight loss, initial goal of 10% weight loss and reassess after goal achieved, maximum weight loss of ½ pound per week if overweight and 1–2 pounds per week if BMI >30.

Interventions to Promote Weight Management

Patients with BMI >30 or >27 with Other Risk Factors or Diseases

All of the above plus:

  • Consider referral to a program that provides guidance on nutrition, physical activity, and psychosocial concerns.
  • Consider pharmacotherapy only for patients with increased medical risk because of their weight with co-existing risk factors or comorbidities (monitor for weight loss and medication side effects; periodically review need for medication).
  • Insurance coverage for weight loss medications varies; consult health plan for eligibility.

Frequency: At each periodic health exam; more frequently at the discretion of the physician

Surgical Treatment

Patients with BMI >40 or BMI >35 and Uncontrolled Comorbid Conditions3

  • Weight loss surgery should be considered only for patients in whom other methods of treatment have failed and who have clinically severe obesity (i.e., BMI >40 or BMI >35 with life-threatening comorbid conditions3) [B].
  • Evaluate for psychological factors that adversely affect surgical outcomes.
  • Insurance coverage for bariatric surgery varies; consult health plan for eligibility.

3 Comorbidities: Severe cardiac disease (CHD, pulmonary hypertension, congestive heart failure, and cardiomyopathy); Type 2 diabetes, obstructive sleep apnea and other respiratory disease (chronic asthma, hypoventilation syndrome, Pickwickian syndrome); end-organ damage; pseudo-tumor cerebri; gastroesophageal reflux disease; hypertension; hyperlipidemia; severe joint or disk disease if interferes with daily functioning.

Definitions:

Levels of Evidence for the Most Significant Recommendation

  1. Randomized controlled trials
  2. Controlled trials, no randomization
  3. Observational studies
  4. Opinion of expert panel

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Michigan Quality Improvement Consortium. Management of overweight and obesity in the adult. Southfield (MI): Michigan Quality Improvement Consortium; 2007 Mar. 1 p.

ADAPTATION

DATE RELEASED

2005 Mar (revised 2007 March)

GUIDELINE DEVELOPER(S)

Michigan Quality Improvement Consortium - Professional Association

SOURCE(S) OF FUNDING

Michigan Quality Improvement Consortium

GUIDELINE COMMITTEE

Michigan Quality Improvement Consortium Medical Director's Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Physician representatives from participating Michigan Quality Improvement Consortium health plans, Michigan State Medical Society, Michigan Osteopathic Association, Michigan Association of Health Plans, Michigan Department of Community Health and Michigan Peer Review Organization

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Michigan Quality Improvement Consortium. Identification, evaluation, and treatment of overweight and obesity in the adult. Southfield (MI): Michigan Quality Improvement Consortium; 2005 Mar. 1 p.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on November 27, 2005. The updated information was verified by the guideline developer on December 19, 2005. The NGC summary was updated by ECRI Institute on July 11, 2007. The updated information was verified by the guideline developer on July 16, 2007.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which may be reproduced with the citation developed by the Michigan Quality Improvement Consortium.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo